Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

CMS finalizes physician fee schedule, delaying controversial coding change

CMS finalized the Physician Fee Schedule and Quality Payment Program, delaying a controversial coding change that would have resulted in a payment cut for doctors.

Thumbnail

CMS finalizes new payment model for home health, boosts reimbursements for 2019

CMS finalized the 2019 home health prospective payment system, cementing a new payment model for the post-acute care space in 2020 and increasing payments for 2019.

Thumbnail

FDA clears 23andMe genetic testing to market on drug metabolism

The FDA will allow genetic testing company 23andMe to market personal genome reports as a direct-to-consumer test of a person’s ability to metabolize some medications to help inform discussions with healthcare providers.

Thumbnail

Maine health systems to combine into $3B entity

The hospital and other healthcare provider members of MaineHealth in Portland, Maine, will combine into one nonprofit entity beginning Jan. 1.

Thumbnail

38% of Americans unaware ACA is still in effect

A large chunk of the American population doesn’t know when the open enrollment period is to purchase healthcare insurance, according to a recent study by insuranceQuotes. And recent political moves have contributed to confusion among Americans.

Thumbnail

$5.6B acquisition of LifePoint Health approved by shareholders

A $5.6 billion merger between LifePoint Health and RCCH Healthcare Partners, which is owned by private equity firm Apollo Global Management, has been approved by LifePoint’s shareholders.

Thumbnail

Insurers and payers are setting vastly different healthcare prices

Healthcare insurance companies and payers negotiate rates with providers for services and care delivered to consumers, but not all prices are negotiated the same.

Thumbnail

Volume remains high, but healthcare deal values drop

Healthcare deals were still happening at a quick clip during the third quarter of the year, but the value of deals declined, according to the latest analysis from PwC.

Around the web

The FTC alleges that pharmacy benefit managers have set up a system where they get rich, while patients are forced to pay rising insulin costs. The agency also called out drug manufacturers such as Eli Lilly, Sanofi and Novo Nordisk, saying their own actions have raised serious concerns.

In the post-COVID era, wages for permanent RNs are rising, and wages for travelers are decreasing. A new report tracked these trends and more. 

Two medical device companies have announced a transaction that could shake up the U.S. electrophysiology market. 

Trimed Popup
Trimed Popup